Trade Omega Healthcare - OHI CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.07 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.024068% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.001846% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 20% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Omega Healthcare Investors Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 27.03 |
Open* | 27.21 |
1-Year Change* | -5.98% |
Day's Range* | 27.14 - 27.44 |
52 wk Range | 24.81-33.71 |
Average Volume (10 days) | 2.69M |
Average Volume (3 months) | 47.78M |
Market Cap | 6.33B |
P/E Ratio | 15.53 |
Shares Outstanding | 234.27M |
Revenue | 878.24M |
EPS | 1.74 |
Dividend (Yield %) | 9.91124 |
Beta | 0.98 |
Next Earnings Date | May 1, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 17, 2023 | 27.00 | -0.54 | -1.96% | 27.54 | 27.78 | 26.97 |
Mar 16, 2023 | 27.84 | -0.17 | -0.61% | 28.01 | 28.05 | 27.52 |
Mar 15, 2023 | 28.36 | 0.29 | 1.03% | 28.07 | 28.44 | 27.59 |
Mar 14, 2023 | 28.58 | 0.82 | 2.95% | 27.76 | 28.71 | 27.73 |
Mar 13, 2023 | 27.51 | 0.42 | 1.55% | 27.09 | 28.09 | 27.09 |
Mar 10, 2023 | 27.40 | -0.55 | -1.97% | 27.95 | 28.30 | 27.31 |
Mar 9, 2023 | 28.10 | -0.07 | -0.25% | 28.17 | 28.41 | 27.97 |
Mar 8, 2023 | 28.16 | 0.77 | 2.81% | 27.39 | 28.35 | 27.33 |
Mar 7, 2023 | 27.57 | 0.24 | 0.88% | 27.33 | 27.69 | 27.20 |
Mar 6, 2023 | 27.37 | 0.25 | 0.92% | 27.12 | 27.44 | 27.07 |
Mar 3, 2023 | 27.02 | 0.00 | 0.00% | 27.02 | 27.26 | 26.98 |
Mar 2, 2023 | 27.02 | 0.50 | 1.89% | 26.52 | 27.14 | 26.52 |
Mar 1, 2023 | 26.63 | 0.06 | 0.23% | 26.57 | 26.72 | 26.22 |
Feb 28, 2023 | 26.75 | -0.21 | -0.78% | 26.96 | 27.14 | 26.72 |
Feb 27, 2023 | 26.94 | -0.03 | -0.11% | 26.97 | 27.25 | 26.91 |
Feb 24, 2023 | 26.87 | 0.18 | 0.67% | 26.69 | 26.94 | 26.50 |
Feb 23, 2023 | 27.04 | -0.08 | -0.29% | 27.12 | 27.25 | 26.87 |
Feb 22, 2023 | 26.99 | -0.50 | -1.82% | 27.49 | 27.64 | 26.97 |
Feb 21, 2023 | 27.44 | -0.53 | -1.89% | 27.97 | 27.98 | 27.27 |
Feb 17, 2023 | 28.15 | -0.32 | -1.12% | 28.47 | 28.70 | 28.02 |
Omega Healthcare Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total revenue | 900.827 | 908.385 | 881.682 | 928.83 | 892.381 | 1062.81 |
Revenue | 900.827 | 908.385 | 881.682 | 928.83 | 892.381 | 1062.81 |
Total Operating Expense | 391.082 | 647.123 | 610.288 | 641.496 | 748.288 | 807.757 |
Selling/General/Admin. Expenses, Total | 55.712 | 62.263 | 70.197 | 57.869 | 97.886 | 142.361 |
Depreciation / Amortization | 267.062 | 287.591 | 281.279 | 301.683 | 329.924 | 342.014 |
Unusual Expense (Income) | 68.308 | 297.269 | 57.39 | 58.296 | 84.773 | 76.518 |
Operating Income | 509.745 | 261.262 | 271.394 | 287.334 | 144.093 | 255.052 |
Interest Income (Expense), Net Non-Operating | -175.62 | -219.665 | 0.345 | 0.814 | -0.879 | |
Gain (Loss) on Sale of Assets | 50.208 | 53.912 | 24.774 | 55.696 | 19.113 | 161.609 |
Net Income Before Taxes | 384.333 | 105.921 | 296.513 | 343.844 | 162.327 | 416.08 |
Net Income After Taxes | 382.928 | 102.673 | 293.503 | 341 | 157.402 | 412.24 |
Minority Interest | -16.952 | -4.491 | -12.306 | -10.824 | -4.218 | -11.563 |
Equity In Affiliates | 0.439 | 2.237 | 0.381 | 10.947 | 6.143 | 16.062 |
Net Income Before Extra. Items | 366.415 | 100.419 | 281.578 | 341.123 | 159.327 | 416.739 |
Net Income | 366.415 | 100.419 | 281.578 | 341.123 | 159.327 | 416.739 |
Income Available to Common Excl. Extra. Items | 366.415 | 100.419 | 281.578 | 341.123 | 159.327 | 416.739 |
Income Available to Common Incl. Extra. Items | 366.415 | 100.419 | 281.578 | 341.123 | 159.327 | 416.739 |
Diluted Net Income | 366.415 | 100.419 | 281.578 | 341.123 | 159.327 | 416.739 |
Diluted Weighted Average Shares | 201.635 | 206.79 | 209.711 | 222.125 | 235.104 | 244.338 |
Diluted EPS Excluding Extraordinary Items | 1.81722 | 0.48561 | 1.3427 | 1.53573 | 0.67769 | 1.70558 |
Dividends per Share - Common Stock Primary Issue | 2.92 | 2.54 | 2.64 | 2.65 | 2.68 | 2.68 |
Diluted Normalized EPS | 1.90666 | 1.62635 | 1.49664 | 1.54733 | 0.94849 | 1.36055 |
Other, Net | 10.412 | -0.581 | ||||
Interest Expense (Income) - Net Operating | 201.422 | 208.715 | 223.389 | 234.604 | ||
Cost of Revenue, Total | 14.933 | 12.316 | 12.26 | |||
Gross Profit | 913.897 | 880.065 | 1050.55 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total revenue | 273.768 | 257.42 | 281.672 | 249.949 | 249.315 |
Revenue | 273.768 | 257.42 | 281.672 | 249.949 | 249.315 |
Cost of Revenue, Total | 2.729 | 3.001 | 3.272 | 3.258 | 3.603 |
Gross Profit | 271.039 | 254.419 | 278.4 | 246.691 | 245.712 |
Total Operating Expense | 220.847 | 175.468 | 194.815 | 216.627 | 167.739 |
Selling/General/Admin. Expenses, Total | 15.128 | 18.736 | 40.883 | 67.614 | 18.209 |
Depreciation / Amortization | 84.849 | 85.799 | 86.097 | 85.269 | 82.752 |
Interest Expense (Income) - Net Operating | 58.521 | 58.879 | 58.979 | 58.225 | 58.145 |
Unusual Expense (Income) | 59.62 | 9.053 | 5.584 | 2.261 | 5.03 |
Operating Income | 52.921 | 81.952 | 86.857 | 33.322 | 81.576 |
Gain (Loss) on Sale of Assets | 100.342 | 4.123 | 56.169 | 0.975 | 113.637 |
Other, Net | 0.231 | 0.54 | -0.767 | -0.585 | -0.455 |
Net Income Before Taxes | 153.494 | 86.615 | 142.259 | 33.712 | 194.758 |
Net Income After Taxes | 152.536 | 85.676 | 141.283 | 32.745 | 193.533 |
Minority Interest | -4.388 | -2.34 | -3.888 | -0.947 | -5.549 |
Equity In Affiliates | 11.83 | 1.187 | 1.552 | 1.493 | 1.623 |
Net Income Before Extra. Items | 159.978 | 84.523 | 138.947 | 33.291 | 189.607 |
Net Income | 159.978 | 84.523 | 138.947 | 33.291 | 189.607 |
Income Available to Common Excl. Extra. Items | 159.978 | 84.523 | 138.947 | 33.291 | 189.607 |
Income Available to Common Incl. Extra. Items | 159.978 | 84.523 | 138.947 | 33.291 | 189.607 |
Diluted Net Income | 159.978 | 84.523 | 138.947 | 33.291 | 189.607 |
Diluted Weighted Average Shares | 239.907 | 243.908 | 246.617 | 246.921 | 247.556 |
Diluted EPS Excluding Extraordinary Items | 0.66683 | 0.34654 | 0.56341 | 0.13482 | 0.76592 |
Dividends per Share - Common Stock Primary Issue | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 |
Diluted Normalized EPS | 0.49815 | 0.36653 | 0.3597 | 0.13988 | 0.32996 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and Short Term Investments | 93.687 | 85.937 | 10.3 | 24.117 | 163.535 | 20.534 |
Cash & Equivalents | 93.687 | 85.937 | 10.3 | 24.117 | 163.535 | 20.534 |
Total Receivables, Net | 240.035 | 279.334 | 347.377 | 408.213 | 245.074 | 263.074 |
Accounts Receivable - Trade, Net | 240.035 | 279.334 | 347.377 | 27.122 | 10.408 | 11.259 |
Total Assets | 8949.26 | 8773.3 | 8590.88 | 9796.12 | 9497.45 | 9638.48 |
Property/Plant/Equipment, Total - Net | 6326.02 | 6279.13 | 6183.79 | 7216.1 | 6705.24 | 6789.09 |
Property/Plant/Equipment, Total - Gross | 7566.36 | 7655.96 | 7746.41 | 8985.99 | 8702.15 | 8949.79 |
Accumulated Depreciation, Total | -1240.34 | -1376.83 | -1562.62 | -1787.43 | -1996.91 | -2160.7 |
Goodwill, Net | 643.474 | 644.69 | 643.95 | 644.415 | 651.737 | 651.417 |
Intangibles, Net | 6.779 | 5.534 | 3.207 | 28.013 | 1.94 | 1.616 |
Long Term Investments | 650.714 | 401.481 | 163.307 | 211.372 | 678.844 | 675.444 |
Note Receivable - Long Term | 896.189 | 947.574 | 1215.48 | 1192.79 | 885.313 | 835.086 |
Other Long Term Assets, Total | 66.457 | 97.57 | 2.36 | 14.185 | 85.475 | 265.028 |
Other Assets, Total | 25.903 | 32.053 | 21.101 | 56.916 | 80.291 | 137.188 |
Accrued Expenses | 266.224 | 214.523 | 207.729 | 251.902 | 242.305 | 240.283 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 5090.52 | 5218.21 | 5146.44 | 5660.7 | 5655.57 | 5731.64 |
Total Long Term Debt | 4366.85 | 4572.16 | 4540.62 | 5136.14 | 5169.25 | 5253.54 |
Long Term Debt | 4366.85 | 4572.16 | 4540.62 | 5136.14 | 5169.25 | 5253.54 |
Deferred Income Tax | 9.906 | 17.747 | 13.599 | 11.35 | 10.766 | 8.2 |
Minority Interest | 353.241 | 333.167 | 320.043 | 201.166 | 194.731 | 201.388 |
Other Liabilities, Total | 94.29 | 80.619 | 64.443 | 60.138 | 38.519 | 28.233 |
Total Equity | 3858.75 | 3555.09 | 3444.44 | 4135.43 | 3841.88 | 3906.84 |
Common Stock | 19.614 | 19.831 | 20.235 | 22.663 | 23.119 | 23.906 |
Additional Paid-In Capital | 4861.41 | 4936.3 | 5074.54 | 5992.73 | 6152.89 | 6427.57 |
Retained Earnings (Accumulated Deficit) | -968.45 | -1370.89 | -1608.69 | -1840.11 | -2321.36 | -2542.43 |
Other Equity, Total | -53.827 | -30.15 | -41.652 | -39.858 | -12.768 | -2.2 |
Total Liabilities & Shareholders’ Equity | 8949.26 | 8773.3 | 8590.88 | 9796.12 | 9497.45 | 9638.48 |
Total Common Shares Outstanding | 196.142 | 198.309 | 202.346 | 226.631 | 231.199 | 239.061 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Cash and Short Term Investments | 51.376 | 100.824 | 102.664 | 20.534 | 491.247 |
Cash & Equivalents | 51.376 | 100.824 | 102.664 | 20.534 | 491.247 |
Total Receivables, Net | 248.097 | 240.457 | 253.622 | 263.074 | 283.164 |
Accounts Receivable - Trade, Net | 11.428 | 10.948 | 16.658 | 11.259 | 13.172 |
Total Assets | 9822.8 | 9759.05 | 9779.95 | 9638.48 | 10014.6 |
Property/Plant/Equipment, Total - Net | 7191.37 | 7089.23 | 7094.42 | 6789.09 | 6796.95 |
Property/Plant/Equipment, Total - Gross | 9261.19 | 9228.33 | 9268.97 | 8949.79 | 9009.13 |
Accumulated Depreciation, Total | -2069.82 | -2139.1 | -2174.55 | -2160.7 | -2212.18 |
Goodwill, Net | 651.679 | 651.697 | 651.354 | 651.417 | 651.024 |
Intangibles, Net | 1.856 | 1.772 | 1.689 | 1.616 | 1.564 |
Long Term Investments | 660.122 | 667.383 | 638.531 | 675.444 | 710.029 |
Note Receivable - Long Term | 890.068 | 857.162 | 873.737 | 835.086 | 819.577 |
Other Long Term Assets, Total | 12.444 | 39.071 | 24.869 | 265.028 | 96.296 |
Other Assets, Total | 115.792 | 111.456 | 139.062 | 137.188 | 164.754 |
Accrued Expenses | 224.539 | 236.257 | 231.26 | 240.283 | 230.378 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 5869.41 | 5746.99 | 5743.96 | 5731.64 | 6096.77 |
Total Long Term Debt | 5407.88 | 5272.56 | 5273.05 | 5253.54 | 5628.37 |
Long Term Debt | 5407.88 | 5272.56 | 5273.05 | 5253.54 | 5628.37 |
Deferred Income Tax | 10.249 | 9.645 | 8.798 | 8.2 | |
Minority Interest | 194.938 | 197.965 | 201.48 | 201.388 | 212.013 |
Other Liabilities, Total | 31.799 | 30.561 | 29.37 | 28.233 | 26.012 |
Total Equity | 3953.39 | 4012.06 | 4035.99 | 3906.84 | 3917.83 |
Common Stock | 23.338 | 23.756 | 23.893 | 23.906 | 23.82 |
Additional Paid-In Capital | 6226.54 | 6377.24 | 6425.72 | 6427.57 | 6401.21 |
Retained Earnings (Accumulated Deficit) | -2319.72 | -2393.46 | -2415.1 | -2542.43 | -2513.51 |
Other Equity, Total | 23.23 | 4.523 | 1.476 | -2.2 | 6.318 |
Total Liabilities & Shareholders’ Equity | 9822.8 | 9759.05 | 9779.95 | 9638.48 | 10014.6 |
Total Common Shares Outstanding | 233.386 | 237.57 | 238.939 | 239.061 | 238.206 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Net income/Starting Line | 383.367 | 104.91 | 293.884 | 351.947 | 163.545 | 428.302 |
Cash From Operating Activities | 624.773 | 577.912 | 499.373 | 553.747 | 708.256 | 722.136 |
Cash From Operating Activities | 267.062 | 287.591 | 281.279 | 301.683 | 329.924 | 342.014 |
Non-Cash Items | 16.742 | 272.919 | 51.018 | 24.001 | 244.906 | 45.846 |
Cash Taxes Paid | 4.922 | 4.141 | 4.772 | 5.097 | 6.974 | 6.288 |
Cash Interest Paid | 148.326 | 182.832 | 211.863 | 205.943 | 216.206 | 214.406 |
Changes in Working Capital | -42.398 | -87.508 | -126.808 | -123.884 | -30.119 | -94.026 |
Cash From Investing Activities | -1113.91 | -285.133 | -173.219 | -378.953 | -89.057 | -524.173 |
Capital Expenditures | -1028.73 | -472.107 | -244.56 | -517.519 | -180.774 | -710.937 |
Other Investing Cash Flow Items, Total | -85.177 | 186.974 | 71.341 | 138.566 | 91.717 | 186.764 |
Cash From Financing Activities | 576.296 | -303.815 | -410.701 | -153.959 | -485.548 | -341.117 |
Financing Cash Flow Items | 227.478 | 7.476 | 46.659 | 110.492 | -14.436 | -74.297 |
Total Cash Dividends Paid | -474.331 | -525.229 | -552.189 | -585.421 | -633.28 | -637.648 |
Issuance (Retirement) of Stock, Net | -3.775 | 19.977 | 73.878 | 400.307 | 148.114 | 274.011 |
Issuance (Retirement) of Debt, Net | 826.924 | 193.961 | 20.951 | -79.337 | 14.054 | 96.817 |
Foreign Exchange Effects | 0.084 | 0.568 | -0.59 | 0.874 | 0.527 | 0.007 |
Net Change in Cash | 87.245 | -10.468 | -85.137 | 21.709 | 134.178 | -143.147 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 164.366 | 251.229 | 394.064 | 428.302 | 195.156 |
Cash From Operating Activities | 175.975 | 378.327 | 565.607 | 722.136 | 132.202 |
Cash From Operating Activities | 84.849 | 170.648 | 256.745 | 342.014 | 82.752 |
Non-Cash Items | -40.241 | -8.916 | -26.055 | 45.846 | -99.091 |
Cash Taxes Paid | 1.509 | 3.072 | 5.028 | 6.288 | 1.716 |
Cash Interest Paid | 67.538 | 105.634 | 166.934 | 214.406 | 60.478 |
Changes in Working Capital | -32.999 | -34.634 | -59.147 | -94.026 | -46.615 |
Cash From Investing Activities | -396.33 | -387.143 | -452.152 | -524.173 | 177.338 |
Capital Expenditures | -604.31 | -624.236 | -707.83 | -710.937 | -117.824 |
Other Investing Cash Flow Items, Total | 207.98 | 237.093 | 255.678 | 186.764 | 295.162 |
Cash From Financing Activities | 108.559 | -54.286 | -174.979 | -341.117 | 161.237 |
Financing Cash Flow Items | -28.199 | 14.23 | -69.039 | -74.297 | -5.26 |
Total Cash Dividends Paid | -158.298 | -316.52 | -477.068 | -637.648 | -160.641 |
Issuance (Retirement) of Stock, Net | 57.635 | 147.437 | 272.429 | 274.011 | -26.174 |
Issuance (Retirement) of Debt, Net | 237.421 | 100.567 | 98.699 | 96.817 | 353.312 |
Foreign Exchange Effects | 0.136 | 0.104 | -0.029 | 0.007 | -0.407 |
Net Change in Cash | -111.66 | -62.998 | -61.553 | -143.147 | 470.37 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 14.5673 | 34126382 | 216159 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 9.834 | 23037874 | 1280009 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 5.6285 | 13185834 | 285758 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8041 | 4226475 | 160524 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.3652 | 3198243 | -13296 | 2022-12-31 | LOW |
LSV Asset Management | Investment Advisor | 1.282 | 3003236 | 208400 | 2022-12-31 | LOW |
Federated Hermes Equity Management Company of Pennsylvania | Investment Advisor | 1.1896 | 2786743 | -9903 | 2022-12-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 1.0784 | 2526393 | 93835 | 2022-12-31 | LOW |
Mellon Investments Corporation | Investment Advisor/Hedge Fund | 0.8833 | 2069226 | 229759 | 2022-12-31 | LOW |
Newton Investment Management North America, LLC | Investment Advisor | 0.8514 | 1994584 | -417332 | 2022-12-31 | MED |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.8133 | 1905387 | 143514 | 2022-12-31 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7941 | 1860371 | 116503 | 2022-12-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7544 | 1767337 | -22632 | 2022-12-31 | LOW |
PGIM Fixed Income | Investment Advisor | 0.7087 | 1660296 | 663269 | 2022-12-31 | HIGH |
DWS Investments UK Limited | Investment Advisor | 0.5706 | 1336742 | 199803 | 2022-12-31 | MED |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.5594 | 1310418 | -1052507 | 2022-12-31 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.4844 | 1134845 | -408052 | 2022-12-31 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 0.4671 | 1094284 | 1585 | 2022-12-31 | LOW |
BNY Mellon Asset Management | Investment Advisor | 0.4506 | 1055698 | -1157 | 2022-12-31 | LOW |
abrdn Inc. | Investment Advisor/Hedge Fund | 0.4372 | 1024212 | -45790 | 2022-12-31 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Omega Healthcare Company profile
Omega Healthcare REIT (OHI) is an American real estate investment trust focused on Skilled Nursing Facilities (SNF) as well as Assisted Living Facilities (ALF). Founded in 2003 and headquartered in Hunt Valley, Maryland, USA, the company owns a portfolio of 972 healthcare facilities across 42 US states and in the UK. Omega Healthcare partners with 77 operators and employs approximately 12,000 staff members globally. Omega Healthcare is listed on the New York Stock Exchange (NYSE). Follow the Omega Healthcare REIT share price (OHI) at Capital.com.Industry: | Healthcare REITs |
Suite 3500
200 International Circle
HUNT VALLEY
MARYLAND 21030
US
Income Statement
- Annual
- Quarterly
News

Ripple/SEC Lawsuit: News And Update
Ripple and the US Securities and Exchange Commission are still awaiting a ruling
15:14, 20 March 2023
S&P 500 holds its ground after banking rout ahead of FOMC meeting
Equity indices recover some momentum after the bailout of Credit Suisse
09:07, 17 March 2023
GBP/USD latest: US CPI, UK spring budget, banking shares rout
GBP/USD runs into resistance after a three-day rally as risk appetite shifts
14:07, 15 March 2023
What now after US jobs data? - FX, Equities, Commodities outlook
Markets reacted to a mixed jobs reading in the US as traders look ahead to this month's FOMC meeting
14:06, 10 March 2023
EXCLUSIVE-BlackRock fast-tracks eviction of ESG violators from MSCI-linked ETFs
Halves removal time to 45 days at most from 90 days
11:50, 9 March 2023People also watch
Market analysis

Polygon price prediction: What is polygon (MATIC)?
15:44, 20 March 2023
Ethereum price prediction 2030-2050: Will it fit your retirement plan?
15:27, 20 March 2023
UBS Group shareholders
14:20, 20 March 2023Still looking for a broker you can trust?
Join the 500.000+ traders worldwide that chose to trade with Capital.com